Clinical evidence shows multifocal lenses improve control of myopic progression in children with high myopia, suggesting their lasting effect.
Both MFSCLs and DIMS have demonstrated efficacy in delaying myopic progression in children with high myopia. The MFSCLs will give children better control up to the age of 12; after that, they remain a good option.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: